Brolucizumab-dbll jekiseni

Zvemukati

• Usati wagamuchira brolucizumab-dbll jekiseni,
• Mimwe mhedzisiro kubva kujekiseni brolucizumab-dbll inogona kuve yakakomba. Kana iwe ukasangana nechimwe cheizvi zviratidzo, danaidza chiremba wako nekukurumidza kana kuwana kurapwa kwekukurumidzira:

Brolucizumab-dbll jekiseni inoshandiswa kurapa kunyorova-zvine chekuita nezera macular degeneration (AMD; chirwere chichienderera mberi cheziso chinokonzeresa kurasikirwa kwekugona kuona chakatwasuka kumberi uye chingaite kuti zvive zvakaoma kuverenga, kutyaira, kana kuita zvimwe zviitiko zvezuva nezuva) . Brolucizumab-dbll iri mukirasi yemishonga inonzi vascular endothelial grow factor A (VEGF-A) vanopikisa. Inoshanda nekumisa isina kujairika yeropa rekukura uye kubuda mu (z) maziso izvo zvinogona kukonzera kurasikirwa kwemaonero.

Brolucizumab-dbll inouya semhinduro (mvura) inoiswa jekiseni muziso nachiremba. Inowanzo kupihwa muhofisi yechiremba kamwe chete pamazuva makumi maviri neshanu kusvika makumi matatu nemakumi matatu ematanhatu ekutanga, uye kamwe chete pamasvondo masere kusvika gumi nemaviri.

Usati wagamuchira jekiseni re brolucizumab-dbll, chiremba wako achachenesa ziso rako kudzivirira hutachiona uye kuvhara ziso rako kudzikisira kusagadzikana panguva yejekiseni. Unogona kunzwa kumanikidzwa muziso rako kana mushonga ukajowa. Mushure mejekiseni rako, chiremba wako anozofanirwa kuongorora maziso ako usati wabva muhofisi.

Brolucizumab-dbll inodzora yakanyorova AMD, asi hairape. Chiremba wako anokucherechedza zvakanyatsoona kuti brolucizumab-dbll inoshanda sei kwauri. Taura nachiremba wako nezvekuti unofanira kuramba uchirapa kwenguva yakareba sei ne brolucizumab-dbll.

Kumbira wemishonga wako kana chiremba kopi yemashoko emugadziri wemurwere.

Mushonga uyu unogona kupihwa zvimwe zvinoshandiswa; bvunza chiremba wako kana wemishonga kuti uwane rumwe ruzivo.

Usati wagamuchira brolucizumab-dbll jekiseni,

• udza chiremba wako uye wemishonga kana uri weergoria kune brolucizumab-dbll, chero mimwe mishonga, kana chero chinhu chinosanganiswa mu brolucizumab-dbll jekiseni. Kumbira wako wemishonga kuti uwane runyorwa rwezvigadzirwa.
• udza chiremba wako uye wemishonga kuti ndeipi imwe mishonga yekunyorera uye isina kunyoreswa, mavitamini, zvinowedzera zvinovaka muviri, uye mishonga yemiti yauri kutora kana kuronga kutora.
• udza chiremba wako kana uine chirwere mukati kana kumativi eziso. Chiremba wako angangokuudza kuti haufanire kugamuchira jekiseni brolucizumab-dbll.
• udza chiremba wako kana iwe uine chero mamiriro ehutano.
• udza chiremba wako kana iwe uine pamuviri kana kuronga kuva nepamuviri. Iwe haufanire kuve nepamuviri panguva yekurapa kwako ne brolucizumab-dbll jekiseni uye kwemwedzi mumwe mushure meyako yekupedzisira dosi. Kana iwe ukava nepamuviri iwe uchinge uchigamuchira brolucizumab-dbll jekiseni, fonera chiremba wako.
• udza chiremba wako kana iwe uchiyamwisa. Usamwisa-zamu iwe uchinge uchinge uchigamuchira brolucizumab-dbll jekiseni uye kwemwedzi mumwe mushure meyako yekupedzisira dosi.
• iwe unofanirwa kuziva kuti brolucizumab-dbll jekiseni inogona kukonzera matambudziko ekuona nguva pfupi uchinge wagamuchira iyo jekiseni. Usatyaire mota kana kushandisa michina kudzamara chiono chako chadzokera pane zvakajairwa.

Kunze kwekunge chiremba wako akakuudza neimwe nzira, ramba uchidya zvakajairika.

Kana iwe ukarasikirwa nguva yekugamuchira brolucizumab-dbll jekiseni, fonera chiremba wako nekukurumidza sezvazvinogona.

Mimwe mhedzisiro kubva kujekiseni brolucizumab-dbll inogona kuve yakakomba. Kana iwe ukasangana nechimwe cheizvi zviratidzo, danaidza chiremba wako nekukurumidza kana kuwana kurapwa kwekukurumidzira:

• kurwadziwa kweziso, kutsvuka, kana kunzwisisika kuchiedza
• shanduko pane zvakaratidzwa
• kuona '' mafloats '' kana madiki madiki
• kubuda ropa mukati kana kumativi eziso
• kuzvimba kweziso kana eyelid
• mapundu, mikoko, kuvaviwa, kana kutsvuka

Brolucizumab-dbll inogona kukonzera mamwe mhedzisiro. Fonera chiremba wako kana uine chero matambudziko asina kujairika paunenge uchigamuchira mushonga uyu.

Kana iwe ukawana chakakomba mhedzisiro, iwe kana chiremba wako ungatumira chirevo kuchirongwa cheKudya neDrug Administration's (FDA) MedWatch Yakashata Chiitiko Chirongwa online (http://www.fda.gov/Safety/MedWatch) kana nefoni ( 1-800-332-1088).

Chengetedza zvese zvakagadzwa nachiremba wako.

Kumbira wemishonga wako chero mibvunzo yauinayo nezve brolucizumab-dbll jekiseni.

Izvo zvakakosha kuti iwe uchengete yakanyorwa rondedzero yeese emushonga uye asiri ekunyora (pamusoro-e-pikisheni) mishonga yauri kutora, pamwe nezvimwe zvigadzirwa zvakaita sevhitamini, zvicherwa, kana zvimwe zvekuwedzera zvekudya. Iwe unofanirwa kuuya nerondedzero iyi iwe nguva imwe neimwe paunoshanyira chiremba kana kana iwe uchigamuchirwa kuchipatara. Izvo zvakare zvakakosha ruzivo kutakura newe kana zvikaitika zvechimbi-chimbi.

• Beovu^®